VANGUARD GROUP INC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$2,420,718
-23.9%
1,729,0840.0%0.00%
Q2 2023$3,181,515
-26.1%
1,729,084
-2.4%
0.00%
Q1 2023$4,305,161
+69.9%
1,771,6710.0%0.00%
Q4 2022$2,533,490
-35.8%
1,771,671
+0.1%
0.00%
Q3 2022$3,949,000
+7.7%
1,770,7490.0%0.00%
Q2 2022$3,665,000
-28.6%
1,770,7490.0%0.00%
Q1 2022$5,136,000
-10.3%
1,770,749
-0.7%
0.00%
Q4 2021$5,724,000
-19.6%
1,783,048
-11.3%
0.00%
Q3 2021$7,117,000
+11.7%
2,010,2960.0%0.00%
Q2 2021$6,373,000
-22.3%
2,010,296
-15.7%
0.00%
Q1 2021$8,206,000
+35.8%
2,385,209
-0.5%
0.00%
Q4 2020$6,042,000
+20.3%
2,397,798
+0.7%
0.00%
Q3 2020$5,023,000
-6.1%
2,380,837
-0.3%
0.00%
Q2 2020$5,348,000
-6.4%
2,387,211
+5.7%
0.00%
Q1 2020$5,714,000
+0.6%
2,258,751
+4.6%
0.00%
Q4 2019$5,678,000
-27.1%
2,158,840
-0.2%
0.00%
Q3 2019$7,787,000
+2.4%
2,163,032
-4.1%
0.00%
Q2 2019$7,601,000
+28.5%
2,255,686
+4.1%
0.00%
Q1 2019$5,916,000
+57.7%
2,167,097
+60.6%
0.00%
Q4 2018$3,751,000
-66.5%
1,349,026
-50.3%
0.00%
Q3 2018$11,188,000
+0.3%
2,715,398
+26.3%
0.00%
Q2 2018$11,160,000
+2.2%
2,150,272
+7.9%
0.00%
Q1 2018$10,923,000
-29.5%
1,993,364
+4.9%
0.00%
-100.0%
Q4 2017$15,486,000
-21.8%
1,900,127
+0.4%
0.00%0.0%
Q3 2017$19,815,000
+2.4%
1,892,492
+8.0%
0.00%0.0%
Q2 2017$19,350,000
+38.8%
1,752,680
+5.2%
0.00%0.0%
Q1 2017$13,943,000
+31.7%
1,665,758
+9.2%
0.00%0.0%
Q4 2016$10,590,000
+40.2%
1,525,857
+2.8%
0.00%
Q3 2016$7,553,000
-15.4%
1,483,859
-0.7%
0.00%
-100.0%
Q2 2016$8,925,000
+46.9%
1,494,933
+11.9%
0.00%
Q1 2016$6,077,000
+5.9%
1,335,510
+4.8%
0.00%
Q4 2015$5,737,000
-96.3%
1,274,911
-81.5%
0.00%
-100.0%
Q3 2015$155,565,000
+4090.9%
6,875,776
+461.3%
0.01%
Q2 2015$3,712,000
+10.5%
1,224,865
+7.5%
0.00%
Q1 2015$3,360,000
-31.6%
1,139,042
+2.9%
0.00%
Q4 2014$4,915,000
-13.2%
1,106,966
+0.7%
0.00%
Q3 2014$5,663,000
+0.1%
1,099,748
+2.0%
0.00%
Q2 2014$5,658,000
+40.7%
1,077,727
+11.5%
0.00%
Q1 2014$4,021,000
+62.3%
966,451
+13.9%
0.00%
Q4 2013$2,477,000
+20.1%
848,265
+3.6%
0.00%
Q3 2013$2,063,000
+35.4%
818,812
+11.7%
0.00%
Q2 2013$1,524,000732,7210.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders